
Sunday, July 06, 2025 5:33:29 AM
By the way a private company has more leeway to release public information on funding partners. Some of the investment funds you find back in Lightwave which of course doesn’t need IPO’ing anymore like Celestial, It’s already on the Nasdaq and Lightwave carries the full weight of Wallstreet (trading) forces.
If you would listen to the Lightwave ASM presentation, you will find out the serviceable market for Lightwave for over 400 Gbps ( per lane), the number of modulators, the possible Lightwave material content with a 60% gross margin, and ( in analogy with Universal Display the licensing fee as a % of the OLED display value). You can create volume/ value scenarios based on marketshare assumptions and calculate EBIDTA numbers. From there you can calculate company value estimates, I have done that. Up to you to create your own. Succes !
What you will find out is that the current Lightwave share price is very much undervalued.
Recent LWLG News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:41:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:39:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:32:46 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/20/2025 08:54:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2025 08:17:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/16/2025 08:11:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2025 09:02:04 PM
- Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 04/30/2025 08:05:23 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/28/2025 09:10:02 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/28/2025 09:19:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/21/2025 09:11:35 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/21/2025 09:08:27 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/18/2025 09:03:04 PM
- Lightwave Logic to Host Annual Meeting of Shareholders on May 15, 2025 • PR Newswire (US) • 03/17/2025 12:30:00 PM
- Lightwave Logic to Attend the 37th Annual ROTH Conference • PR Newswire (US) • 03/11/2025 12:30:00 PM
- Lightwave Logic and Polariton Technologies Expand Technical Partnership to Accelerate Introduction of 400Gb/s per lane and beyond for AI and Datacenter Optical Links • PR Newswire (US) • 03/10/2025 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2025 10:41:24 PM
- Lightwave Logic to Host Special Call on March 13, 2025 • PR Newswire (US) • 03/03/2025 09:01:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2025 07:47:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 09:06:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2025 09:37:05 PM
- Lightwave Logic to Attend the 2025 SPIE Photonics West Conference • PR Newswire (US) • 01/27/2025 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2025 09:04:19 PM
- Lightwave Logic Director Frederick Leonberger to Retire from Board of Directors and Transition to Company's Advisory Board • PR Newswire (US) • 01/03/2025 01:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2025 10:02:39 PM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM